Cargando…

Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis

The incidence of hepatocellular carcinoma (HCC) associated with non-alcoholic fatty liver disease (NAFLD) is rapidly increasing. We aimed to elucidate the genetic basis of NAFLD-associated HCC and identify candidate targets for chemoprevention. Twenty HCC tumors, distant liver and matched tails from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Jennifer, Jiao, Jingjing, Smoot, Kristin, Watt, Gordon P., Zhao, Chen, Song, Xingzhi, Stevenson, Heather L., McCormick, Joseph B., Fisher-Hoch, Susan P., Zhang, Jianhua, Futreal, P. Andrew, Beretta, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047684/ https://www.ncbi.nlm.nih.gov/pubmed/30034633 http://dx.doi.org/10.18632/oncotarget.25685

Ejemplares similares

Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics
por: Jiao, Jingjing, et al.
Publicado: (2021)

Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors
por: Jiao, Jingjing, et al.
Publicado: (2018)

Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity
por: Jiao, Jingjing, et al.
Publicado: (2016)

13 CHEMOPREVENTIVE EFFECT OF STATIN ON HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH CIRRHOSIS
por: Al-Yaman, Wael A., et al.
Publicado: (2021)

The Precarious Health of Young Mexican American Men in South Texas, Cameron County Hispanic Cohort, 2004–2015
por: Watt, Gordon P., et al.
Publicado: (2016)

Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican‐American Population of South Texas
por: Kwan, Suet Ying, et al.
Publicado: (2020)

Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican Americans
por: Watt, Gordon P., et al.
Publicado: (2020)

Mexican American and South Asian population-based cohorts reveal high prevalence of type 2 diabetes and crucial differences in metabolic phenotypes
por: Watt, Gordon P, et al.
Publicado: (2018)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
por: Cotrim, Helma P., et al.
Publicado: (2016)

Disparities in the toll of the COVID-19 pandemic on publishing: Evidence from submissions to Hormones and Behavior
por: McCormick, Cheryl M.
Publicado: (2020)

Recommended Levels of Physical Activity Are Associated with Reduced Risk of the Metabolic Syndrome in Mexican-Americans
por: Wu, Shenghui, et al.
Publicado: (2016)

Undiagnosed Diabetes and Pre-Diabetes in Health Disparities
por: Fisher-Hoch, Susan P., et al.
Publicado: (2015)

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
por: Rivera, Chantal A, et al.
Publicado: (2010)

Transition from pre-diabetes to diabetes and predictors of risk in Mexican-Americans
por: Wu, Shenghui, et al.
Publicado: (2017)

Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid
por: Yoo, Wonbeak, et al.
Publicado: (2017)

Metabolic Health Has Greater Impact on Diabetes than Simple Overweight/Obesity in Mexican Americans
por: Wu, Shenghui, et al.
Publicado: (2016)

Challenges and strategies for recruitment of minorities to clinical research and trials
por: Fisher-Hoch, Susan P., et al.
Publicado: (2023)

Study on chemoprevention of hepatocellular carcinoma by ginseng: an introduction to the protocol.
Publicado: (2001)

Chemopreventive Potential of Green Tea Catechins in Hepatocellular Carcinoma
por: Shimizu, Masahito, et al.
Publicado: (2015)

Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma
por: Liao, Chen-Yi, et al.
Publicado: (2015)

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Glycemic Control and Bone Turnover in Older Mexican Americans with Type 2 Diabetes
por: Rianon, Nahid J., et al.
Publicado: (2018)

Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
por: Jeong, Soung Won
Publicado: (2020)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
por: Hymel, Emma, et al.
Publicado: (2022)

Genetic alterations in carcinogenesis and chemoprevention.
por: Rosin, M P
Publicado: (1993)

The Definition of Insulin Resistance Using HOMA-IR for Americans of Mexican Descent Using Machine Learning
por: Qu, Hui-Qi, et al.
Publicado: (2011)

Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease
por: Sabotta, Caroline M., et al.
Publicado: (2022)

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey
por: Alves, Venancio Avancini Ferreira, et al.
Publicado: (2016)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Quercetin and Cancer Chemoprevention
por: Gibellini, Lara, et al.
Publicado: (2011)

Cancer Chemoprevention: Current State of the Art
por: Landis-Piwowar, Kristin R, et al.
Publicado: (2014)

Non-communicable diseases and preventive health behaviors: a comparison of Hispanics nationally and those living along the US-Mexico border
por: Reininger, Belinda M., et al.
Publicado: (2015)

Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma
por: Zhang, Deyu, et al.
Publicado: (2020)

Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas
por: Kwan, Suet-Ying, et al.
Publicado: (2022)

Chemoprevention for breast cancer: current status
por: Boyle, P
Publicado: (2004)

Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma
por: Barone, Michele, et al.
Publicado: (2019)

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
por: Jühling, Frank, et al.
Publicado: (2021)

Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
por: Goh, Myung Ji, et al.
Publicado: (2022)

Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation
por: Crouchet, Emilie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jcg7fmvt2i22nom5g7817b74ql